EP2940031
NUCLEOSIDE PHOSPHORAMIDATE COMPOUNDS FOR USE IN THE TREATMENT OF HCV
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
6.3.2014EP published:
27.9.2017EP application number:
14760567.9
EPO information:
European Patent Register
Max expiry date:
5.3.2034
Title:
NUCLEOSIDE PHOSPHORAMIDATE COMPOUNDS FOR USE IN THE TREATMENT OF HCV
Timeline
Today
6.3.2014EP application
27.9.2017EP Publication
Owner
Name:
Nanjing Sanhome Pharmaceutical Co., Ltd.Address:
Nanjing Economic and Technological Development Zone No. 9 Huizhong Road, 210038, NanjingJiangsu, CN
Inventor
Name:
WANG, YongAddress:
Jiangsu, CN
Name:
ZHAO, LiwenAddress:
Jiangsu, CN
Name:
ZHANG, XianAddress:
Jiangsu, CN
Name:
BI, ShengAddress:
Jiangsu, CN
Name:
GAO, YipingAddress:
Jiangsu, CN
Name:
CHEN, HongyanAddress:
Jiangsu, CN
Name:
WANG, DezhongAddress:
Jiangsu, CN
Name:
NAN, YangAddress:
Jiangsu, CN
Name:
ZHANG, CangAddress:
Jiangsu, CN
Name:
LI, YuxiuAddress:
Jiangsu, CN
Name:
ZHANG, DiAddress:
Jiangsu, CN
Priority
Number:
201310075423Date:
8.3.2013Country:
CN
Classification
Categories:
C07H 19/10, A61K 31/7072, A61P 31/14